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An ovine adenovirus which may be the prototype for a new group of adenoviruses has been engineered as a gene transfer
vector. One recombinant containing a 0.95-kb insertion expressed a sheep parasite antigen from the ovine adenovirus major
late promoter and tripartite leader sequences. It was shown that insertions of at least 4.3 kb were tolerated at either one
of two sites in the genome without the introduction of a compensating deletion. The unique structure of this viral genome
was further emphasized by the discovery that four open reading frames at the right hand end show significant identity to
each other but not to other sequences in the databases. Two other unrelated open reading frames were also present. RT-
PCR analysis identified two transcripts in this region which were derived from a promoter which was located very close to,
or within the ITR sequence. Splicing removed all but the first and last of the ORFs from these RNAs, suggesting that some
sequences might be nonessential for replication in vitro. A 2-kb deletion, which removed or truncated the internal reading
frames was introduced into the region without affecting virus viability. The carrying capacity of OAV recombinants should
therefore be at least 6.3 kb. The relative packaging capacity of OAV (114%) therefore exceeds that of Ad5 (105%), although
a comparison of virus particle sizes by electron microscopy showed that OAV was smaller than Ad5. These studies improve
the potential utility of OAV as a gene transfer vector. q 1997 Academic Press
INTRODUCTION (e.g., Both et al., 1993; Graham and Prevec, 1992; Morin
et al., 1987). Perhaps not surprisingly, first generation
The molecular biology of human adenoviruses (Ad)
Ad vectors generated an immune response which re-
has been extensively studied over three decades and is
sulted in virus clearance and diminution of therapeutic
now quite well understood. Because Ads infect a wide gene expression, due in large part to residual promoter
variety of cell types and are generally of low pathogenic- activity in the vector genome which resulted in the syn-
ity in otherwise healthy individuals (Horwitz 1996), there thesis of immunogenic viral capsid proteins (Yang et al.,
is considerable interest in utilizing them as vectors for 1995; Yang and Wilson, 1995). The use of vectors car-
gene therapy (reviewed in Ali et al., 1994; Smith 1995). rying mutations which further attenuated viral protein
Vectors based largely on human Ad5 have been engi- synthesis resulted in improved expression of the recom-
neered to carry up to 8– 9 kb of foreign DNA (Bett et al., binant gene (Engelhardt et al., 1994; Yang et al., 1994).
1994; Caravokyri and Leppard 1995) and this is adequate Other strategies intended to further suppress the im-
for many purposes. More recently, helper-dependent vec- mune response to the vector have also been investi-
tors which can carry up to 30 kb of foreign DNA have gated. These include the incorporation of adenovirus im-
been constructed (Fisher et al., 1996; Kochanek et al., munomodulatory genes in the vector (Efrat et al., 1995;
1996). Improved cell lines for the production of recombi- Lee et al., 1995), intrathymic inoculation to induce toler-
nants free from contaminating wild-type virus have also ance (DeMatteo et al., 1995) and the induction of tran-
been produced (Imler et al., 1996; Wang et al., 1995; Yeh sient immunosuppression using cyclosporin A (Fang et
et al., 1996). al., 1995), FK506 (Vilquin et al., 1995), or IL-12 (Yang et
As the Ad genome does not integrate into the host al., 1995). However, such approaches can do little to
chromosome, delivery of genes by recombinant Ads is overcome immunity to Ads which may preexist in a host
relatively transient and repeated administration of the due to natural infections with these common viruses.
vector may be required, especially for chronic illnesses The use of a nonhuman Ad vector coupled with immune
(Crystal et al., 1995; Sene et al., 1995). However, Ad suppression strategies may provide an alternative ap-
vectors have also been used extensively for delivery of proach for gene delivery to humans.
vaccine antigens where an immune response is desired We have been studying an ovine Ad with a view to
adapting it as an alternative vector. OAV is serotypically
distinct (Boyle et al., 1994) and its nucleotide sequence1 To whom correspondence and reprint requests should be ad-
dressed. (Vrati et al., 1995; Vrati et al., 1996a,b) shows that the
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FIG. 1. Structure of the OAV genome (Vrati et al., 1996) showing the location of insertion sites I and II.
virus has a small genome (29,575 bp) with an atypical that in the plasmid, the ITRs of the viral genome are
structure. OAV is the only fully characterized member of linked through KpnI sites by modified Bluescribe se-
a group of Ads which appear to be significantly different quences (Stratagene, La Jolla, CA) (Vrati et al., 1996c).
from members of the Mastadenovirus genus (Harrach et Other plasmids described below differ in the same way
al., 1997). The virus does not replicate productively in from the corresponding viral genomes whose structures
most nonovine cells in which it has been tested (Boyle are shown in Fig. 2. Mutational insertion of a 20-bp oligo-
et al., 1994), but is clearly capable of infecting some nucleotide sequence at site I created plasmid pOAV200
human cell types (Khatri, Vrati, Boyle, and Both, manu- which carried unique ApaI and NotI sites (Vrati et al.,
script submitted for publication). 1996c) (Fig. 2A). A similar strategy was used to introduce
For the construction of Ad5 recombinants, deletions the same sites at a location 5* to base 26,676, adjacent
were introduced into the nonessential E3 region of the to a termination point for leftward transcripts of ORFs
genome or, replication-defective viruses were made by located at the right hand end of the genome (Vrati et al.,
E1 region replacement because such recombinants 1996a). A 7.1-kb SphI/SalI fragment of pOAV100 was
could be propagated in 293 cells which complemented subcloned into plasmid pALTER-1 (Promega Corp., Madi-
the defect (Berkner 1988; Graham and Prevec 1991; Le- son, WI) and using a mutagenesis kit (Altered sites II,
vrero et al., 1991; Mittal et al., 1995; Morin et al., 1987). Promega Corp.) the unique ApaI and NotI sites were
The unusual genome structure of OAV restricted the op- inserted by using a synthetic oligonucleotide (5* . . . . . .
tions for rationally introducing deletions because of the GGG CCC TGA ATC TGC GGC CGC . . . . . . 3*) con-
unknown function of many sequences. A DNA insertion taining flanking sequences appropriate to the insertion
strategy was therefore pursued. Two potential insertion site. The modified SphI/SalI fragment was then recloned
sites for foreign DNA were identified previously (Vrati into SphI/SalI-cut pOAV100 to construct plasmid
et al., 1996c). However, with this approach it was also pOAV600 (Fig. 2B). pOAV600 was further modified to re-
necessary to consider the potential packaging capacity move 2 kb of nucleotide sequence between the NotI
of OAV. As the capacity of Ad5 is limited to 105% of site and the SalI restriction sites by replacing them with
the size of the wild-type genome (Bett et al., 1993), the the NotI/SalI polylinker sequence from plasmid Blue-
capacity of OAV might have been as little as 1.5 kb script KS/ (Stratagene, La Jolla, CA), creating plasmid
because of the smaller size of the OAV genome (29.5 pOAV603 (Fig. 2B). Plasmid pOAV209 (Fig. 2A) was con-
kb) (Vrati et al., 1996a). Surprisingly, it was found that structed by subcloning plasmid pACYC184 (4,244 bp)
much larger insertions were tolerated without compen- (Rose, 1988) as an XbaI fragment into Bluescript KS/.
sating deletions. An apparent sequence redundancy was The pACYC184 portion was then excised using flanking
also identified in the genome. It was found that portions ApaI and NotI sites and subcloned into ApaI/NotI-cut
of these sequences could be deleted without affecting pOAV200. pOAV209 plasmids (AmpR/CmR) were selected
virus viability, thus potentially improving the utility of OAV and characterized. The plasmid pOAV287Cm was con-
as a vector. structed as an intermediate in the production of pOAV100
as described (Vrati et al., 1996c). Plasmid pOAV216 con-
MATERIALS AND METHODS tained an expression cassette comprising the HCMV en-
hancer/promoter and a human placental alkaline phos-Construction of recombinant plasmids
phatase gene. The alkaline phosphatase sequences
were excised from pAdCBhAP (Fisher and Wilson, 1994)Plasmid pOAV100 (Vrati et al., 1996c), which contains
by partial SalI digestion and cloned into an XhoI sitea full-length infectious copy of the viral genome (Fig. 1),
differs from the corresponding virus, OAV100 (Fig. 2), in adjacent to the HCMV IE enhancer/promoter in a Blue-
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scribe-based plasmid (Khatri et al., manuscript in prepa-
ration). The expression cassette was subcloned as an
ApaI/NotI fragment into pOAV200 (Vrati et al., 1996c).
pOAV205 was constructed by linking the 45W gene from
the sheep parasite Taenia ovis (Johnson et al., 1989) to
the OAV MLP/TLS sequences (Vrati et al., 1996b). The
45W gene, excised as an EcoRI/BamHI fragment, was
linked via an HindIII/EcoRI adapter to plasmid pMT (Kha-
tri et al., manuscript submitted for publication) which had
been cut with HindIII/BglII. The adapter also provided an
in-frame ATG codon. The MLP/TLS/45W cassette was
excised as an ApaI/NotI fragment and subcloned into
pOAV200.
Virus and cell culture
OAV287 was grown in the fetal ovine lung cell line,
CSL503 (Boyle et al., 1994). Ad5 was propagated in 293
cells (Graham et al., 1977). Conditions for the transfection
of CSL503 cells with pOAV100 and related plasmids and
virus rescue have been previously described (Vrati et al.,
1996c). As viruses were derived from a single, purified
plasmid DNA, and because rescue events occur at low
frequency, viruses were used without plaque purification
FIG. 2. Structure of recombinant OAV genomes showing insertions
after confirming that the genome structure was correct in (A) site I and (B) site II and their sizes. OAV100 corresponds to the
by restriction enzyme digestion. To monitor expression wild-type OAV sequence except for a silent point mutation at base
8291 which removes an SphI site. OAV603 has a nett 2 kb deletionfrom the OAV MLP/TLS elements CSL503 cells were in-
between the NotI and SalI sites. In the corresponding plasmids fromfected with recombinant virus OAV205 at an m.o.i. of 10.
which the viruses were derived, e.g., pOAV100, the ITRs are linkedCells were radiolabeled for 1 hr with 35[S]methionine at
through KpnI sites to modified Bluescribe sequences (Vrati et al., 1996).
23 and 35 hr pi and 45W protein was recovered by immu-
noprecipitation using a polyclonal antiserum as de-
scribed previously (Xu et al., 1995). and examined in a Hitachi H7000 scanning transmission
electron microscope at 140,000 and 100 kV. Photo-
Analysis of RNA transcripts using RT-PCR graphic images were digitized into ‘‘Image Pro’’ (Media
Cybernetics, Silver Spring, MD). Vertex to vertex diame-Total RNA was prepared from OAV-infected (m.o.i. 10
ters of intranuclear viruses were recorded. Only virusesPFU/cell) or uninfected CSL503 cells at 12 and 24 hr
with electron-dense cores were examined. Magnificationpostinfection using Quickprep mRNA purification kits
of the microscope was calibrated with 2160 lines/mm(Pharmacia Biotech). cDNA was transcribed using re-
crossed-ruled standard grating.verse transcriptase and amplified for 40 cycles as de-
scribed (Vrati et al., 1995). The plus sense primers corre-
sponded to bases 26,731–26,747 (PCR1) and 27,250– RESULTS
27,272 (PCR5) of the genome. The minus sense primer
Construction of OAV recombinantscorresponded to bases 28,973–29,006 (PCR3) and
29,442–29,462 (PCR2). Several recombinant OAVs have been constructed by
inserting expression cassettes at site I. The first of these
Electron microscopy
(OAV205; Fig. 2A) carried a 0.95-kb cassette which was
designed to express the 45W antigen from Taenia ovisCSL503 cells infected with OAV or 293 cells infected
with Ad5 were harvested at 48 and 24 hr postinfection, (Johnson et al., 1989) under the control of the OAV MLP
and TLS sequences (Vrati et al., 1996b). When CSL503respectively, when the monolayers showed 30–50% cpe.
Cells were scraped, pelleted, and fixed in 2.5% (v/v) glu- cells were infected with OAV205 and harvested at 24
and 36 hr pi, the 45W antigen (expected size 25 kDa) wastaraldehyde in cacodylate buffer for 40 min. Following
fixation the cells were washed in the same buffer (3 1 detected by radioimmunoprecipitation as a monomer of
apparent size 30 kDa and a presumed trimer of 80 – 9015 min), postfixed in 1% aqueous (w/v) osmium tetroxide
for 1 hr, washed in distilled water (31 5 min), dehydrated kDa, showing that the MLP/TLS elements were func-
tional (Fig. 3, lanes 2 and 3). Subsequently recombinantsin graded alcohol (70, 95, and 100%) and infiltrated and
polymerized in Spurr’s resin. Ultrathin sections were cut containing cassettes of 1.4 and 1.95 kb were constructed
AID VY 8452 / 6a2c$$$$62 03-03-97 10:37:43 vira AP: Virology
65OVINE ADENOVIRUS RECOMBINANTS
at least 4.3 kb in separate viruses without compensating
deletions. OAV can therefore package DNA which is at
least 114% of the wild-type genome.
Sequence redundancy in the OAV genome
At the right hand end of the OAV genome (Fig. 1) there
are two groups of open reading frames separated from
each other by 1 kb of A/T rich sequence (Vrati et al.,
1996a). The 5* penultimate group may be the equivalent
of human Ad early region E4. The six ORFs adjacent to
the ITR were tentatively considered as the E3 region
equivalent (Vrati et al., 1996a). Initial searches of the
databases revealed no significant homology between
any of these ORFs and other protein or nucleotide se-
quences. However, direct comparison of the reading
frames using NCBI Blast programs revealed, unexpect-
edly, that four of the six ORFs in the region were closely
related to each other at the nucleotide and protein levels.
When the 3* terminal 2.9 kb of the genome was com-
FIG. 3. Expression of the T. ovis 45W antigen from OAV MLP/TLS
pared with itself, sequences within the 22.3, 20.5, andsequence elements. OAV205 was used to infect CSL503 cells which
18.1-kDa ORFs were clearly related to each other whilewere radiolabeled at 23 and 35 hr pi. The 45W protein was recovered by
immunoprecipitation and analyzed on a polyacrylamide gel. Uninfected
cells (lane 1), infected cells at 24 hr (lane 2) and 36 hr (lane 3). (M)
marker proteins of the sizes indicated.
(Khatri et al., manuscript submitted for publication). More
recently, a recombinant expressing the alkaline phos-
phatase reporter gene under the control of the HCMV
enhancer/promoter (3.1-kb cassette) was also con-
structed. Clearly the size of these cassettes exceeded
the theoretical packaging capacity of OAV based on the
Ad5 precedent.
Packaging capacity of OAV
As described previously (Vrati et al., 1996c), the site II
SalI sequence can be cut, end-filled, and ligated, dis-
rupting a 22.3-kDa ORF, without affecting the viability of
the virus in vitro. To determine whether the observed
packaging capacity could be extended, rescue of plas-
mid pOAV287Cm, which carried the 4.3-kb pACYC184
sequences in the SalI site, was attempted. Transfection
of pOAV287Cm yielded the corresponding virus
OAV287Cm (Fig. 2B) which had a BamHI profile compris-
ing fragments of 11.75, 6.7, 5.2, 4.2, 3.5, 1.17, and 1.14
kb (Fig. 4C, lane 1). Of these, the 11.75- and 1.17-kb
fragments (lane 1, arrowed) characterized the new virus
compared with OAV100 (Fig. 4C, lane 2).
As an alternative, plasmid pOAV209 was constructed
by inserting pACYC184 sequences at site I (Fig. 2A). This FIG. 4. BamHI fragments of recombinant OAV genomes or plasmids
analyzed by agarose gel electrophoresis. Analysis of (A) viral genomesvirus was also successfully rescued, the genome produc-
OAV603 (lane 1) and OAV100 (lane 2). (B) viral genome OAV209 (laneing the expected fragments of 11.2, 6.7, 5.2, 4.2, 3.5, 1.42,
1) and plasmid pOAV209 (lane 2), (C) viral genomes OAV287Cm (lane1.14, and 0.45 kb (Fig. 4B, lane 1), compared with the
1) and OAV100 (lane 2). Lane M contains l HindIII markers of sizes
plasmid pOAV209 (Fig. 4B, lane 2). In this case the diag- 23, 9.4, 6.6, 4.4, 2.3, and 2.0 kb. Arrows highlighting bands in lanes 1
nostic fragments were 11.2 and 4.2 kb in size (lane 1, characterize the new viruses. (*) Fragments derived from an ovine
genomic satellite DNA.arrowed). Thus, sites I and II accommodated insertions of
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FIG. 5. Arrangement of open reading frames at the right hand end of the OAV genome and RT-PCR products derived from transcripts of the
region. The SalI site at base 28,674 and the insertion point in OAV600 at base 26,676 are indicated. Related ORFs are shown with bold arrows.
(l) Potential initiation codons. (C and c) Location of PCR primers. (*) Termination point at base 26,652 for rightward transcripts.
postinfection and cDNA was synthesized using dT15 asthe 5* end of the 12.9-kDa sequence also showed homol-
primer. It was previously determined that some leftwardogy to the other three (data not shown). At the amino
transcripts of the region terminated at nucleotide 26,683acid level all four of the ORFs (indicated in bold arrows,
(Vrati et al., 1996a). The primer PCR1 was located nearFig. 5) showed significant identity with each other (Fig.
this site and primer PCR2 spanned the first methionine6) but not with other proteins in the database. The 24.9
codon of the leftward strand (see Methods). As relatedand 7.4-kDa ORFs were unrelated to any other sequence
Ad transcripts often share common 5* and 3* termini thisat both the nucleotide and proteins levels.
primer pair was designed to amplify differentially spliced
transcripts which potentially represented the whole re-Mapping of RNA transcripts
gion. PCR products of 750–850 bp were detected after
To analyze transcription of these ORFs, RNA was pre- 40 amplification cycles when RNA from in infected, but
not uninfected cells was analyzed. These were just visi-pared from uninfected and infected cells at 12 and 24 hr
FIG. 6. Comparison of ORFs at the amino acid level. Amino acid sequences for ORFs shown with bold arrows in Fig. 5 were compared using
the programme Seqvu (Garvan Institute, Sydney, NSW). Where two or more of the four sequences were identical, residues were boxed and shaded.
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ble at 12 hr and clearly present at 24 and 48 hr pi (Khatri comprising fragments of 6.7, 5.8, 5.2, 4.2, 3.5, 1.14, and
0.95 kb (Fig. 4A, lane 1). Of these, the 5.8- and 0.95-kbet al., manuscript submitted for publication). The tran-
scripts must have been produced from a promoter lo- fragments characterized the new virus (lane 1, arrowed).
Thus, deletion of four ORFs and truncation of another didcated upstream of PCR2, i.e., within 113 bases from the
5* end of the leftward strand (46 of these form the ITR). not affect the viability of the OAV in vitro. This 2-kb
deletion coupled with insertions of at least 4.3 kb whichAs the PCR fragments were considerably smaller than
the genomic distance between the primers, they were are tolerated at sites I and II suggests that in principle,
OAV recombinants should be capable of carrying at leastprobably derived from RNAs which had been spliced.
Cloning and sequencing of the PCR fragments revealed 6.3 kb of foreign DNA.
a splice junction common to the two products. This was
Growth of recombinant viruseslocated 5* to the GT dinucleotide at base 29,125, immedi-
ately 3* to the 12.9-kDa ORF. The 3* splice sites were
To determine whether large insertions or deletions had
distinct, accounting for the size difference of the PCR
a noticeable effect on the ability of OAV to replicate in
fragments. These junctions were located 3* to the AG
vitro, growth curves were determined for wild-type OAV
dinucleotides at bases 27,427 (within the 24.9-kDa ORF)
and recombinants OAV603 and OAV209. CSL503 cells
and 27,163 (immediately upstream of the second Met in
(105 cells in a 24 well plate) were inoculated with virus
the 20.5-kDa ORF) (Fig. 5). The ratio of the PCR products
at an m.o.i. of 1 PFU/cell. After 1 hr the inoculum was
also changed with time postinfection. At 12 and 24 hr
removed, the cells were twice washed with PBS, and
the larger product was the dominant species (ratio 80/
fresh medium was added. Residual virus in the inoculum
20). At 48 hr p.i. the ratio had changed to 45/55, sug-
and virus adsorbed to the cells after 1 hr was titrated as
gesting a change in the relative use of the splice junc-
the zero time point. Subsequently, virus levels were ti-
tions. The PCR2/5 primer pair (Fig. 5), which was in-
trated in cells and supernatants harvested at 12, 24, 36,
tended to identify any transcripts for the 24.9-kDa product
60, and 96 hr. Titers were expressed as TCID50/ml deter-which were derived from the upstream promoter, only
mined from quadruplicate dilutions of each sample. Com-
produced a product of500 bp. The size of this fragment
pared with wild-type OAV, deletion of 2 kb from the
was consistent with its derivation from the larger RNA
right hand end of the genome (OAV603) had little effect
transcript identified by the PCR1/2 primer pair. Thus, tran-
on the level of virus which remained cell-associated (Fig.
scripts coding for the 24.9-kDa ORF, if produced, may
7A) and the level of virus in the medium was reduced by
not be derived from the promoter upstream of PCR2. No
about one log10 (Fig. 7B). OAV209, which carried the 4.3-PCR product was detected using the PCR1/PCR3 primer
kb insertion at site I, grew in cells to a final titer that was
pair, consistent with the apparent spliced removal of se-
0.5–1.0 log10 lower than WT and OAV603 (Fig. 7A). Thequences for four of the six ORFs from transcripts of the
titer in the medium was very similar to OAV603 and about
region (Fig. 5).
one log10 lower than WT virus (Fig. 7B). Similar results
with respect to relative titers of each virus in the cells
Identification of nonessential sequences and supernatant were obtained in an independent exper-
iment (data not shown). Thus, these modifications to the
The apparent coding redundancy and RNA splicing
genome had no dramatic effect on virus growth.
pattern in this portion of the genome suggested that dele-
tions in the region might be tolerated. Identification of Particle size and packaging capacity of OAV
such nonessential sequences would potentially improve
the packaging capacity of OAV recombinants. To investi- The major Ad capsid protein is hexon. As the Ad5 and
OAV hexon proteins are similar in molecular weight (Vratigate this ApaI/NotI sites were introduced into pOAV100
between the A/T-rich sequences and the site at which et al., 1996a) we considered whether the icosahedral
particles might also have a similar size, allowing rela-leftward transcripts terminated, producing plasmid
pOAV600 (Fig. 2B). This minor insertion did not affect tively more DNA to be packaged into OAV because of
its smaller genome size. To measure relative particlevirus viability as OAV600 was rescued after transfection
of pOAV600 into CSL503 cells (data not shown). Next, sizes, human 293 and CSL503 cells were infected with
Ad5 and OAV, respectively, and ultrathin sections of in-pOAV600 was converted to plasmid pOAV603 (Fig. 2B)
by replacing 2 kb of sequence between the NotI and fected cells containing intranuclear virus aggregates
were prepared (Fig. 8). One hundred complete Ad5 andSalI sites with a short polylinker. This modification de-
leted sequences coding for the related ORFs 20.5 and OAV particles containing an electron dense core were
identified and measured from vertex to vertex, excluding18.1 kDa, as well as the unique 24.9 and 7.4-kDa ORFs.
The 22.3-kDa ORF was also truncated at its 3* end but the fiber. The mean particle size for Ad5 was 80.0 { 2.7
nM while for OAV it was 76.8 { 2.7 nM. The dimensionsthe 12.9-kDa ORF remained intact (Fig. 5). Transfection
of plasmid pOAV603 yielded the corresponding virus, of these dehydrated Ad5 particles are comparable to the
dimensions of 87–91.4 nM determined for two-, three-,OAV603, which had a BamHI restriction fragment profile
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FIG. 7. Relative growth rates of recombinant and wild-type viruses. CSL503 cells were infected in quadruplicate with the viruses indicated and
the titers were determined for cells and medium at each time point. Titers are expressed as TCID50/ml.
and fivefold axes of hydrated particles (Stewart et al., to be capable of coding for proteins as they contain many
1991). As the Ad5 particle is significantly rounded relative stop codons.
to a perfect icosahedron (Stewart et al., 1991), the ap- Insertion of 4.3 kb of foreign DNA into the genome
proximate volume of the particles is proportional to the (OAV209) did not have a dramatic effect on the growth
cube of the radius. Thus, the volume of the OAV particle of the virus. The viral titer in the cell pellet was reduced
is about 88% of that of Ad5. Despite this OAV was able by about one log10 relative to WT OAV when a stock was
to package relatively more DNA. grown. This is consistent with the data in Figs. 7A and
7B. Similarly, deletion of2 kb in OAV603 had little effect
DISCUSSION on growth, only reducing the titer in the medium by about
one log10 (Fig. 7B). Given the apparent redundancy of theThe structure and base composition of the OAV287
deleted sequences, this was not too surprising. In two
genome is atypical compared with other members of
experiments, for both OAV209 and OAV603, the amount
the Mastadenovirus genus (e.g., Davison et al., 1993;
of virus in the medium was slightly lower than that ob-
Sprengel et al., 1994). It is also distinct from the Aviade-
served for wild-type OAV, although cellular virus levelsnoviruses (Chiocca et al., 1996). OAV287 may therefore
were similar. Thus, the growth of similar recombinantsbe the prototype of a new group of adenoviruses (Har-
carrying potentially therapeutic genes should not be sig-rach et al., 1997). Considerable work is still required to
nificantly impaired.identify all the structural proteins of OAV and to deter-
The apparent redundancy among four of the ORFs atmine the function of nonstructural regions, many of which
the right hand end of OAV was very surprising givenshow little or no detectable homology with known Ads
the otherwise compact nature of the OAV genome. The(Vrati et al., 1996a). The construction of recombinant
unrelated 7.4- and 24.9-kDa ORFs are also nonessentialOAVs was more difficult because of the lack of identifi-
for virus viability in vitro as both were deleted in OAV603.able nonessential regions in the genome. An insertion
RT-PCR analysis of the region identified two transcriptsstrategy was therefore pursued, recognizing that there
which were derived from an uncharacterized promotermight have been constraints on the amount of DNA which
which must be located near or within the right hand ITR.could be packaged. Surprisingly, OAV was able to pack-
These transcripts used a common upstream splice siteage DNA comprising at least 114% of its wild-type ge-
but had different downstream splice junctions. The nettnome without a compensating deletion. As the OAV ge-
result of splicing in both transcripts was to leave thenome is 6.3 kb shorter than that of Ad5, presumably
12.9-kDa ORF intact. The 20.5-kDa ORF retained one orthis more than compensates for the slightly smaller size
two potential initiation codons. Whether this protein isof the OAV particle size. Construction of OAV recombi-
translated from a distal ORF in the transcript has notnants carrying at least 6.3 kb of foreign DNA may be
been determined. As the intervening ORFs were removedpossible as2 kb of apparently nonessential sequences
by splicing, it appeared that they were not required. Con-in the genome were also identified. In theory, OAV should
sistent with this, their deletion in pOAV603 yielded abe able to accommodate expression cassettes as large
viable virus. Thus, a minimal requirement for virus viabil-as that required for the CFTR gene (4.5 kb) used in
ity in vitro may be the expression of the 12.9-kDa ORF,gene therapy for cystic fibrosis (Rosenfeld et al., 1992).
although we have not yet tried to delete the entire region.It may also prove possible to delete the 1 kb of A/T-
In addition, no PCR product was detected for the primerrich sequence (Fig. 1) which has no counterpart in other
Ads (Vrati et al., 1996a). These sequences do not appear pair PCR1/PCR3 (Fig. 5). These data do not rule out the
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FIG. 8. Electron micrographs of OAV in infected CSL503 cells. (A) Low magnification. Bar represents 1 mm. (N) Nucleus, (V) virus. (B) High
magnification. Bar represents 100 nm. Only intranuclear viruses containing electron dense cores (arrow) were measured.
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Graham, F. L., Prevec, L., and Andrew, M. E. (1993). Protective immu-possibility that other promoters and transcripts may exist
nity to rotavirus-induced diarrhoea is passively transferred to new-in the region. However, any longer RNAs which shared
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